SCHEMBL159558

SCHEMBL159558

Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](COC(=O)c2cc(O)cc(C(=O)O)c2)O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.56
ENPP1 P22413 3/20 0.55
P2RY1 P47900 2/20 0.55
GSK3A P49840 2/20 0.49
RPS6KA3 P51812 2/20 0.49
MAPK14 Q16539 2/20 0.49
ABCB1 P08183 1/20 0.48
NT5E P21589 1/20 0.44
HIF1A Q16665 1/20 0.44
DTYMK P23919 2/20 0.43
DNPH1 O43598 1/20 0.43
PRKAB2 O43741 1/20 0.43
TRPM2 O94759 1/20 0.43
LDHA P00338 1/20 0.43
ADRB2 P07550 1/20 0.43
FBP1 P09467 1/20 0.43
SRC P12931 1/20 0.43
ADORA1 P30542 1/20 0.43
P2RY2 P41231 1/20 0.43
PRKAG1 P54619 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338780 0.87 POLB (0.60) POLBENPP1P2RY1GSK3ARPS6KA3
SCHEMBL161527 0.85 POLB (0.55) POLBENPP1P2RY1GSK3ARPS6KA3
SCHEMBL338677 0.82 POLB (0.57) POLBENPP1P2RY1GSK3ARPS6KA3
SCHEMBL8623380 0.82 POLB (0.65) POLBENPP1P2RY1NT5EHIF1A
SCHEMBL3259692 0.82 POLB (0.65) POLBENPP1P2RY1NT5EHIF1A
SCHEMBL112026 0.81 POLB (0.49) POLBENPP1P2RY1GSK3ARPS6KA3
SCHEMBL113466 0.81 POLB (0.53) POLBENPP1P2RY1GSK3ARPS6KA3
SCHEMBL10178190 0.81 POLB (0.65) POLBENPP1P2RY1NT5EDTYMK
SCHEMBL8058699 0.81 POLB (0.64) POLBENPP1P2RY1NT5EHIF1A
SCHEMBL1889395 0.81 POLB (0.64) POLBENPP1P2RY1NT5EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242087-B2 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents K.U.LEUVEN RESEARCH & DEVELOPMENT (BE) 2012-08-14 US disclosed
EP-2424874-A1 NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL ANGENTS Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-03-07 EP disclosed
US-20110112046-A9 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2011-05-12 US disclosed
WO-2010125200-A1 NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL ANGENTS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2010-11-04 WO disclosed
US-20100093656-A1 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112046-A9 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS MTAP, POLRMT, PNP POLB 12/4885ENPP1 17/4885P2RY1 575/4885
US-20100093656-A1 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS MTAP, POLRMT, PNP POLB 12/4885ENPP1 17/4885P2RY1 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.